Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients

International Journal of Colorectal Disease

Volumn 24, Issue 3, 2009, Pages 269-274

  Alabi, Andrew A ^a   Suppiah, Aravind ^a   Madden, Leigh A ^a   Monson, John R ^b   Greenman, John ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Lymphangiogenesis; Survival; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 59649099092     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0622-x     Document Type: Article

References (38)

1. UK, C.R., Large Bowel (Colorectal) Cancer Factsheet April 2005.
2. Globocan, International Agency for Research on Cancer. 2002
3. UICC, TNM classification of malignant tumours. 2002 (6th Ed)
4. Wolpin BM, Meyerhardt JA, Mamon HJ et al (2007) Adjuvant treatment of colorectal cancer. CA Cancer J Clin 57:168-185
5. Giuliani F, Colucci G (2007) Cetuximab in colon cancer. Int J Biol Markers 22:S62-S70
6. Moertel CG, Fleming TR, Macdonald JS et al (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 122(5):321-326
7. O'Dwyer ST, Haboubi NY, Johnson JS et al (2001) Detection of lymph node metastases in colorectal carcinoma. Colorectal Dis 3:288-294
8. Pepper MS (2001) Lymphangiogenesis and tumor metastasis: Myth or reality? Clin Cancer Res 7:462-468
9. George ML, Tutton MG, Janssen F et al (2001) VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3:420-427
10. Stacker SA, Achen MG, Jussila L et al (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573-583
11. Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425
12. Kukk E, Lymboussaki A, Taira S et al (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829-3837
13. Joukov V, Sorsa T Kumar V et al (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. Embo J 16:3898-3911
14. Joukov V, Pajusola K, Kaipainen A et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15:1751
15. Paavonen K, Horelli-Kuitunen N, Chilov D et al (1996) Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 93:1079-1082
16. Mohammed RA, Green A, El-Shikh S et al (2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96:1092-1100
17. Yonemura Y, Fushida S, Bando E et al (2001) Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 37:918-923
18. Nishida N, Yano H, Komai K et al (2004) Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 101:1364-1374
19. Furudoi A, Tanaka S, Haruma K et al (2002) Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 62:157-166
20. Rubbia-Brandt L, Terris B, Giostra E et al (2004) Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin Cancer Res 10:6919-6928
21. Liotta LA (1986) Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46:1-7
22. Yang W, Klos K, Yang Y et al (2002) ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer 94:2855-2861
23. Mandriota SJ, Jussila L, Jeltsch M et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. Embo J 20:672-682
24. Duff SE, Saunders M, McCredie V et al (2005) Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer. Clin Oncol (R Coll Radiol) 17:367-371
25. Akagi K, Ikeda Y, Miyazaki M et al (2000) Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 83:887-891
26. Hu WG, Li JW, Feng B et al (2007) Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res 39:229-238
27. Noda E, Maeda K, Inoue T et al (2007) Predictive value of vascular endothelial growth factor-C expression for local recurrence of rectal carcinoma. Oncol Rep 17:1327-1331
28. Onogawa S, Kitadai Y, Tanaka S et al (2004) Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95:32-39
29. Xu T, Chen D (2006) Serum vascular endothelial growth factor-C and Vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance. Journal of Huazhong University of Science and Technology [Med Sci] 26:329-331
30. Tamura M, Ohta Y (2003) Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: A possible diagnostic tool for lymph node metastasis. Cancer 98:1217-1222
31. Kinoshita J, Kitamura K, Kabashima A et al (2001) Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66:159-164
32. Wartiovaara U, Salven P, Mikkola H et al (1998) Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80:171-175
33. Hyodo I, Doi T, Endo H et al (1998) Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer 34:2041-2045
34. Dirix LY, Vermeulen PB, Hubens G et al (1996) Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7:843-848
35. Lee JC, Chow NH, Wang SM, Huang SM (2000) Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36:748-753
36. Nissen NN, Polverini PJ, Koch AE et al (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445-1452
37. George ML, Eccles SA, Tutton MG et al (2000) Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin Cancer Res 6:3147-3152
38. Werther K, Christensen IJ, Nielsen HJ (2002) Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer 8:417-423